US Patent 7982014 FGFR3-IIIc fusion proteins
Patent 7982014 was granted and assigned to Five Prime Therapeutics on July, 2011 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7982014 FGFR3-IIIc fusion proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
